Jiaming Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jiaming Huang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Chunping Zhu
Department of Gastroenterology, Ganzhou People’s Hospital, Ganzhou, China
3 shared publications - Kim G. Smolderen
Yale School of Medicine
3 shared publications Carlos Mena Hurtado
Yale University School of Medicine, New Haven, CT, USA
2 shared publications- Qiuping Gu
Department of Gastroenterology, Ganzhou People's Hospital, Ganzhou, Jiangxi, 341000, China
2 shared publications - Qurat-Ul-Ain Jelani
Vascular Medicine Outcomes Program at Yale University, Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA
2 shared publications Sameer Nagpal
Yale University School of Medicine, New Haven, CT, USA
2 shared publications
Latest Publications
- Open Access
- 3 December 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 850
Endoscopic Histoacryl injection with clips is associated with lower early rebleeding compared to Histoacryl injection alone in the treatment of gastric varices
To assess whether Histoacryl injection with clips is superior to Histoacryl injection alone in terms of efficacy and safety. Patients with gastric varices
- 3 December 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 850
Open AccessEndoscopic Histoacryl injection with clips is associated with lower early rebleeding compared to Histoacryl injection alone in the treatment of gastric varices
To assess whether Histoacryl injection with clips is superior to Histoacryl injection alone in terms of efficacy and safety. Patients with gastric varices
- Open Access
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1651661
Volume of red blood cell transfusion is a risk factor for acute ischemic stroke after non-variceal upper gastrointestinal bleeding
Objective: To determine if the volume of red blood cell (RBC) transfusion is a risk factor for acute ischemic stroke (AIS) in patients with non-variceal upper gastrointestinal bleeding (NVUGIB).Methods: NVUGIB patients who received RBC transfusion between January 2019 and December 2021 were included. Patients were divided into two groups, AIS group and non-AIS group. Propensity score matching was used to match the confounding factors between the two groups. Multivariate logistic regression was used to analyze independent risk factor for AIS in NVUGIB patients. The ROC curve was used to assess the sensitivity and specificity of the factors.Results: The study included 272 NVUGIB patients who received RBC transfusions, with 44 patients in the AIS group and 228 patients in the non-AIS group. After propensity score matching, 38 pairs of patients were successfully matched. Multivariate logistic regression showed that the volume of RBC transfusion was an independent risk factor for AIS in NVUGIB patients. The area under the curve for RBC transfusion volume was 0.811, the sensitivity and specificity were 0.553 and 0.921, respectively.Conclusion: The volume of RBC transfusion is a risk factor for AIS in NVUGIB patients. However, these results need to be validated by multicenter, prospective studies with larger sample sizes.
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1651661
Open AccessVolume of red blood cell transfusion is a risk factor for acute ischemic stroke after non-variceal upper gastrointestinal bleeding
Objective: To determine if the volume of red blood cell (RBC) transfusion is a risk factor for acute ischemic stroke (AIS) in patients with non-variceal upper gastrointestinal bleeding (NVUGIB).Methods: NVUGIB patients who received RBC transfusion between January 2019 and December 2021 were included. Patients were divided into two groups, AIS group and non-AIS group. Propensity score matching was used to match the confounding factors between the two groups. Multivariate logistic regression was used to analyze independent risk factor for AIS in NVUGIB patients. The ROC curve was used to assess the sensitivity and specificity of the factors.Results: The study included 272 NVUGIB patients who received RBC transfusions, with 44 patients in the AIS group and 228 patients in the non-AIS group. After propensity score matching, 38 pairs of patients were successfully matched. Multivariate logistic regression showed that the volume of RBC transfusion was an independent risk factor for AIS in NVUGIB patients. The area under the curve for RBC transfusion volume was 0.811, the sensitivity and specificity were 0.553 and 0.921, respectively.Conclusion: The volume of RBC transfusion is a risk factor for AIS in NVUGIB patients. However, these results need to be validated by multicenter, prospective studies with larger sample sizes.
- Open Access
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1574278
Development of a model for predicting gastrointestinal bleeding in patients with ischemic stroke after dual antiplatelet therapy
Objective: To establish a model for predicting gastrointestinal bleeding in patients with ischemic stroke after dual antiplatelet therapy (DAPT).Methods: A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established based on a retrospective study that involved 1,217 patients diagnosed with ischemic stroke in the Neurology Department of Nanchang University Affiliated Ganzhou Hospital from January 2019 to June 2021. A receiver operating characteristic curve was constructed to evaluate the model’s power. Data from patients with ischemic stroke between July and December 2021 were used to validate the power of the model.Results: A total of 1,217 patients with ischemic stroke between January 2019 and June 2021 were included in the model. The cohort comprised 1,164 patients in the non-gastrointestinal bleeding group and 53 in the gastrointestinal bleeding group. Multivariate logistic regression analysis revealed that age, fibrinogen level, neutrophil-to-lymphocyte ratio, and National Institute of Health Stroke Scale score were independent risk factors for gastrointestinal bleeding. A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established, Logit(P) = −7.269 + 0.074 ×1 + 0.071 ×2 + 0.361 ×3 + 0.082 ×4 (X1, National Institute of Health Stroke Scale score; X2, neutrophil-to-lymphocyte ratio; X3, fibrinogen; X4, activated partial thromboplastin time). Receiver operating characteristic analysis showed that the area under the curve for the model was 0.733. Data from the validation group showed that the area under the curve for the model was 0.665.Conclusion: A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established and demonstrated its predictive ability. Although the predictive ability of the model was not perfect, this was an important attempt. Further studies are needed to establish better models to predict gastrointestinal bleeding.
- 18 June 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1574278
Open AccessDevelopment of a model for predicting gastrointestinal bleeding in patients with ischemic stroke after dual antiplatelet therapy
Objective: To establish a model for predicting gastrointestinal bleeding in patients with ischemic stroke after dual antiplatelet therapy (DAPT).Methods: A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established based on a retrospective study that involved 1,217 patients diagnosed with ischemic stroke in the Neurology Department of Nanchang University Affiliated Ganzhou Hospital from January 2019 to June 2021. A receiver operating characteristic curve was constructed to evaluate the model’s power. Data from patients with ischemic stroke between July and December 2021 were used to validate the power of the model.Results: A total of 1,217 patients with ischemic stroke between January 2019 and June 2021 were included in the model. The cohort comprised 1,164 patients in the non-gastrointestinal bleeding group and 53 in the gastrointestinal bleeding group. Multivariate logistic regression analysis revealed that age, fibrinogen level, neutrophil-to-lymphocyte ratio, and National Institute of Health Stroke Scale score were independent risk factors for gastrointestinal bleeding. A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established, Logit(P) = −7.269 + 0.074 ×1 + 0.071 ×2 + 0.361 ×3 + 0.082 ×4 (X1, National Institute of Health Stroke Scale score; X2, neutrophil-to-lymphocyte ratio; X3, fibrinogen; X4, activated partial thromboplastin time). Receiver operating characteristic analysis showed that the area under the curve for the model was 0.733. Data from the validation group showed that the area under the curve for the model was 0.665.Conclusion: A model for predicting gastrointestinal bleeding in patients with ischemic stroke after DAPT was established and demonstrated its predictive ability. Although the predictive ability of the model was not perfect, this was an important attempt. Further studies are needed to establish better models to predict gastrointestinal bleeding.
- 11 August 2024
- Published by Elsevier in Journal of Cleaner Production
- Vol. 470, 143367
A new paradigm for construction safety management in China: Introducing knowledge graph and accident database into the early-stage of BIM
- 11 August 2024
- Published by Elsevier in Journal of Cleaner Production
- Vol. 470, 143367
A new paradigm for construction safety management in China: Introducing knowledge graph and accident database into the early-stage of BIM
- 6 August 2024
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 127, 110772
Risk factors for gastrointestinal bleeding in patients with intracerebral hemorrhage: A propensity score matching analysis
- 6 August 2024
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 127, 110772
Risk factors for gastrointestinal bleeding in patients with intracerebral hemorrhage: A propensity score matching analysis
- Open Access
- 11 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 650-654
Portal venous blood flow velocity is a factor associated with portal venous thrombosis after partial splenic artery embolization in hepatic cirrhosis patients
Objective: To investigate risk factors for portal venous thrombosis (PVT) after partial splenic artery embolization (PSE) in hepatic cirrhosis patients. Methods: The authors retrospectively analyzed 151 hepatic cirrhosis patients with hypersplenism who underwent partial splenic artery embolization between January 2020 and December 2021. The patients were divided into a PVT group and a non-PVT group according to whether they had PVT after PSE. Univariate analyses were performed to select risk factors for PVT after PSE, and multivariate analysis was used to analyze variates with a value of P less than 0.1 in univariate analysis. Results: There were 151 patients enroled in the study, with 22 patients in the PVT group and 129 patients in the non-PVT group. There was no significant difference in terms of age, sex, smoking, hypertension, diabetes, Child–Pugh between two groups. White blood cell (WBC) and platelet counts after PSE were significantly higher than those before PSE in both the PVT group and non-PVT group. Univariate analysis showed that portal venous blood flow velocity, ligation of oesophageal varices and WBC after PSE were found to have a P value less than 0.1. Multivariate analysis showed that portal venous blood flow velocity was a factor associated with PVT after PSE. Conclusion: Portal venous blood flow velocity was a factor associated with PVT after PSE. Portal venous blood flow velocity should be considered before patients undergo PSE.
- 11 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 650-654
Open AccessPortal venous blood flow velocity is a factor associated with portal venous thrombosis after partial splenic artery embolization in hepatic cirrhosis patients
Objective: To investigate risk factors for portal venous thrombosis (PVT) after partial splenic artery embolization (PSE) in hepatic cirrhosis patients. Methods: The authors retrospectively analyzed 151 hepatic cirrhosis patients with hypersplenism who underwent partial splenic artery embolization between January 2020 and December 2021. The patients were divided into a PVT group and a non-PVT group according to whether they had PVT after PSE. Univariate analyses were performed to select risk factors for PVT after PSE, and multivariate analysis was used to analyze variates with a value of P less than 0.1 in univariate analysis. Results: There were 151 patients enroled in the study, with 22 patients in the PVT group and 129 patients in the non-PVT group. There was no significant difference in terms of age, sex, smoking, hypertension, diabetes, Child–Pugh between two groups. White blood cell (WBC) and platelet counts after PSE were significantly higher than those before PSE in both the PVT group and non-PVT group. Univariate analysis showed that portal venous blood flow velocity, ligation of oesophageal varices and WBC after PSE were found to have a P value less than 0.1. Multivariate analysis showed that portal venous blood flow velocity was a factor associated with PVT after PSE. Conclusion: Portal venous blood flow velocity was a factor associated with PVT after PSE. Portal venous blood flow velocity should be considered before patients undergo PSE.
- 25 May 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107802
Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy
- 25 May 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107802
Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy